Alnylam Pharmaceuticals
Simon Fox is currently the Vice President, Program Lead, Pipeline Strategy & Product Management at Alnylam Pharmaceuticals. Prior to this role, Simon held positions such as Global Commercial Lead and Global Director at CSL Behring, Senior Director Global Marketing at Alexion Pharmaceuticals, Inc., and International Developing Brands Marketing Director at Kyowa Kirin Pharmaceutical Research, Inc. Simon has a strong background in commercial development and marketing within the pharmaceutical industry, with experience in oncology, cardiovascular, and metabolism therapy areas. Simon's educational background includes a PhD in Organic Chemistry from the University of Hull.
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.